Vadastuximab
Product Specifications
UNSPSC Description
Vadastuximab is a humanized monoclonal antibody targeting CD33. Vadastuximab can be used to synthesize an ADC compound, Vadastuximab talirine[1].
Target Antigen
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/vadastuximab.html
Purity
99.23
Solubility
10 mM in DMSO
Smiles
[Vadastuximab]
References & Citations
[1]Eytan M Stein, et al. A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia. Blood. 2018 Jan 25;131(4):387-396.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99329/Vadastuximab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99329/Vadastuximab-SDS-MedChemExpress.pdf
Clinical Information
Phase 3
CAS Number
1436390-64-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
